300760 迈瑞医疗
已收盘 04-30 15:00:00
资讯
新帖
简况
东吴证券:给予迈瑞医疗买入评级
证券之星 · 04-30 22:35
东吴证券:给予迈瑞医疗买入评级
迈瑞医疗(300760.SZ):医疗器械“中国智造”典范
格隆汇 · 04-30 18:18
迈瑞医疗(300760.SZ):医疗器械“中国智造”典范
中国银河:给予迈瑞医疗买入评级
证券之星 · 04-30 16:43
中国银河:给予迈瑞医疗买入评级
【机构调研记录】华宸未来基金调研迈瑞医疗
证券之星 · 04-30 08:02
【机构调研记录】华宸未来基金调研迈瑞医疗
迈瑞医疗(300760.SZ)取得惠泰医疗控制权
智通财经 · 04-29 19:05
迈瑞医疗(300760.SZ)取得惠泰医疗控制权
“数智化”转型赋能,迈瑞医疗如何抢占未来竞争制高点?
市场资讯 · 04-29
“数智化”转型赋能,迈瑞医疗如何抢占未来竞争制高点?
迈瑞医疗(300760)2023年报及2024年一季报点评:业绩增长稳健 收购惠泰医疗进入心血管赛道
光大证券 · 04-28
迈瑞医疗(300760)2023年报及2024年一季报点评:业绩增长稳健 收购惠泰医疗进入心血管赛道
平安证券:给予迈瑞医疗增持评级
证券之星 · 04-28
平安证券:给予迈瑞医疗增持评级
迈瑞医疗获得发明专利授权:“一种麻醉呼吸装置及方法”
证券之星 · 04-28
迈瑞医疗获得发明专利授权:“一种麻醉呼吸装置及方法”
迈瑞医疗(300760)3月31日股东户数6.14万户,较上期增加0.82%
证券之星 · 04-26
迈瑞医疗(300760)3月31日股东户数6.14万户,较上期增加0.82%
迈瑞医疗(300760.SZ)发布一季度业绩,净利润31.6亿元,同比增长22.90%
智通财经 · 04-26
迈瑞医疗(300760.SZ)发布一季度业绩,净利润31.6亿元,同比增长22.90%
迈瑞医疗(300760.SZ)发布2023年度业绩,净利润115.82亿元,同比增长20.56%
智通财经 · 04-26
迈瑞医疗(300760.SZ)发布2023年度业绩,净利润115.82亿元,同比增长20.56%
迈瑞医疗新注册《迈瑞BeneHeart C&S系列自动体外除颤器软件V2.0》项目的软件著作权
证券之星 · 04-25
迈瑞医疗新注册《迈瑞BeneHeart C&S系列自动体外除颤器软件V2.0》项目的软件著作权
4月24日迈瑞医疗现1笔折价14.49%的大宗交易 合计成交244.44万元
证券之星 · 04-24
4月24日迈瑞医疗现1笔折价14.49%的大宗交易 合计成交244.44万元
景顺长城新兴成长混合一季报出炉!刘彦春:偏好具有好的商业模式、在市场化竞争中取得优势的企业
智通财经网 · 04-22
景顺长城新兴成长混合一季报出炉!刘彦春:偏好具有好的商业模式、在市场化竞争中取得优势的企业
脑机接口又传重磅利好!全球最大神经拟态系统诞生,比人脑快200倍
格隆汇 · 04-22
脑机接口又传重磅利好!全球最大神经拟态系统诞生,比人脑快200倍
医药老三,没了1500亿
格隆汇 · 04-21
医药老三,没了1500亿
迈瑞医疗4月19日现1笔大宗交易 成交金额261.31万元
智能小浪 · 04-19
迈瑞医疗4月19日现1笔大宗交易 成交金额261.31万元
《大行》瑞银最新中资股首选股名单(表)
阿斯达克财经 · 04-18
《大行》瑞银最新中资股首选股名单(表)
加载更多
公司概况
公司名称:
深圳迈瑞生物医疗电子股份有限公司
所属行业:
专用设备制造业
上市日期:
2018-10-16
主营业务:
深圳迈瑞生物医疗电子股份有限公司主要从事医疗器械的研发、制造、营销及服务,主要产品涵盖三大领域:生命信息与支持、体外诊断以及医学影像。公司总部设在中国深圳,在北美、欧洲、亚洲、非洲、拉美等地区的超过30个国家设有40家境外子公司;在国内设有17家子公司,超过40家分支机构,形成了庞大的全球化研发、营销及服务网络。公司荣获“2022年度中国医疗设备优秀民族品牌金奖”、“2022峰值TOP 2022年度南山区经济突出贡献企业--工业增加值十强”、“2022年度南山区纳税百强企业(十强)”、“2022年度广东省质量信用A类医疗器械生产企业”、2022年度Wind ESG最佳实践上市公司-A股最佳实践奖、2022年度Wind ESG最佳实践上市公司-A股医疗保健行业最佳实践奖、2022中国医药上市公司ESG竞争力TOP20、第十六届中国上市公司ESG百强、2022年度中经大健康高质量发展企业、第五届中国卓越IR·2021-2022最佳ESG奖、第五届中国卓越IR·2021-2022最佳ESG奖、2022卓越社会责任企业、2023中国宠物医疗行业年度品牌盛典年度科技创新品牌奖和年度筑梦人才品牌奖、瑞派宠物医院突出贡献奖。
发行价格:
48.80
{"stockData":{"symbol":"300760","market":"SZ","secType":"STK","nameCN":"迈瑞医疗","latestPrice":304.59,"timestamp":1714460601000,"preClose":302.11,"halted":0,"volume":4856789,"delay":0,"floatShares":1212000000,"shares":1212000000,"eps":10.0385,"marketStatus":"已收盘","marketStatusCode":5,"change":2.48,"latestTime":"04-30 15:00:00","open":300.61,"high":307.34,"low":300.35,"amount":1482000000,"amplitude":0.0231,"askPrice":304.66,"askSize":30,"bidPrice":304.59,"bidSize":62,"shortable":0,"etf":0,"ttmEps":10.0385,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":302.11,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":332.32,"lowLimit":271.9,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1212441394,"pbRate":10.13,"roa":"--","roe":"9.12%","epsLYR":9.5586,"committee":0.459916,"marketValue":369298000000,"floatMarketCap":369297000000,"peRate":30.342183,"changeRate":0.0082,"turnoverRate":0.004,"status":0},"requestUrl":"/m/hq/s/300760/","defaultTab":"news","newsList":[{"id":"2431327479","title":"东吴证券:给予迈瑞医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431327479","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431327479?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:35","pubTimestamp":1714487738,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对迈瑞医疗进行研究并发布了研究报告《2023年报&2024年一季报点评:业绩符合预期,海外市场加速》,本报告对迈瑞医疗给出买入评级,当前股价为304.59元。自23年3月份以来,国内常规诊疗活动实现了迅速复苏,推动国内IVD全年实现了20%的快速增长,其中试剂收入增长超过25%。最新盈利预测明细如下:该股最近90天内共有19家机构给出评级,买入评级17家,增持评级2家;过去90天内机构目标均价为373.84。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000054647.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431315133","title":"迈瑞医疗(300760.SZ):医疗器械“中国智造”典范","url":"https://stock-news.laohu8.com/highlight/detail?id=2431315133","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2431315133?lang=zh_cn&edition=full","pubTime":"2024-04-30 18:18","pubTimestamp":1714472315,"startTime":"0","endTime":"0","summary":"从追随到引路甚至开创,这个角色的转变,不仅给迈瑞医疗带来的是当下稳健扎实的经营情况,也将成为未来业绩增长的源头活水。","market":"hk","thumbnail":"https://img2.gelonghui.com/e55e7-f59bc4f7-bbc0-4c88-880d-c619f9f3fffd.jpg?guru_height=1080&guru_width=1920","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/e55e7-f59bc4f7-bbc0-4c88-880d-c619f9f3fffd.jpg?guru_height=1080&guru_width=1920"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/725877","is_publish_highlight":false,"gpt_icon":0},{"id":"2431739581","title":"中国银河:给予迈瑞医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431739581","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431739581?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:43","pubTimestamp":1714466589,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对迈瑞医疗进行研究并发布了研究报告《2023年年报及2024年一季报业绩点评:业绩符合预期,进一步向全球龙头迈进》,本报告对迈瑞医疗给出买入评级,当前股价为304.59元。最新盈利预测明细如下:该股最近90天内共有19家机构给出评级,买入评级17家,增持评级2家;过去90天内机构目标均价为373.84。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000034846.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431877341","title":"【机构调研记录】华宸未来基金调研迈瑞医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2431877341","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431877341?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:02","pubTimestamp":1714435354,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及4月29日披露的机构调研信息,华宸未来基金近期对1家上市公司进行了调研,相关名单如下:1)迈瑞医疗 个股亮点:公司有手持式血氧仪、遥测监护系统、中央监护系统等,形成一套整体解决方案华宸未来基金成立于2012年,截至目前,资产管理规模13.18亿元,排名177/203;资产管理规模13.17亿元,排名164/203;管理公募基金数5只,排名174/203;旗下公募基金经理2人,排名187/203。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000014152.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431834731","title":"迈瑞医疗(300760.SZ)取得惠泰医疗控制权","url":"https://stock-news.laohu8.com/highlight/detail?id=2431834731","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431834731?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:05","pubTimestamp":1714388758,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈瑞医疗(300760.SZ)公告称,截至本公告日,成正辉持有惠泰医疗1251.93万股股份,占惠泰医疗总股本的18.72%,持有表决权比例为8.72%。公司通过深迈控及其一致行动人珠海彤升合计持有惠泰医疗1645.56万股股份,占惠泰医疗总股本的24.61%,持有表决权比例为24.61%。惠泰医疗第二届董事会、监事会改组工作已完成,公司取得惠泰医疗控制权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114674.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431871208","title":"“数智化”转型赋能,迈瑞医疗如何抢占未来竞争制高点?","url":"https://stock-news.laohu8.com/highlight/detail?id=2431871208","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2431871208?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:39","pubTimestamp":1714383540,"startTime":"0","endTime":"0","summary":" 2023年,迈瑞医疗营收为349.32亿元,同比增长15.04%,归母净利润为115.82亿元,同比增长20.56%。作为国内医疗器械的绝对龙头,登顶“泰山”的迈瑞医疗也扛起了时代新使命——引领行业“数智化”转型,这也被认为是医疗器械领域未来竞争的制高点。 医疗器械行业关系人类生命健康,而“数智化”将再度提升医疗效率,大幅提升拯救万千生命的能力。“数智化”转型则将为中国医疗工业提供弥合差距、直道超车的绝佳机会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-04-29/doc-inatnyiv2943723.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-04-29/doc-inatnyiv2943723.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430926054","title":"迈瑞医疗(300760)2023年报及2024年一季报点评:业绩增长稳健 收购惠泰医疗进入心血管赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2430926054","media":"光大证券","top":-1,"share":"https://www.laohu8.com/m/news/2430926054?lang=zh_cn&edition=full","pubTime":"2024-04-28 20:35","pubTimestamp":1714307705,"startTime":"0","endTime":"0","summary":"事件:公司发布2023 年报与2024 年一季报。2024 年第一季度,公司实现营业收入93.73 亿元,同比增长12.06%;实现归母净利润31.60 亿元,同比增长22.90%。2023 年营收增长主要源于国内医院常规诊疗活动迅速恢复、海外高端客户群加速突破。截至2024 Q1,公司共获授权专利4,945 件,其中发明专利授权2,346 件。同时,在24 年第一季度,公司推进对心血管细分领域龙头企业惠泰医疗的控制权收购,进入心血管赛道将为公司培育新的增长极,为公司长期稳健发展助力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404282035148b5de31b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404282035148b5de31b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430091867","title":"平安证券:给予迈瑞医疗增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430091867","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430091867?lang=zh_cn&edition=full","pubTime":"2024-04-28 11:04","pubTimestamp":1714273444,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,倪亦道,裴晓鹏近期对迈瑞医疗进行研究并发布了研究报告《国内外齐头并进,经营业绩高质量发展》,本报告对迈瑞医疗给出增持评级,当前股价为288.8元。 维持“推荐”评级。根据国内政策环境变化,调整2024-2026EPS预测为11.57、13.93、16.77元,维持“推荐”评级。最新盈利预测明细如下:该股最近90天内共有19家机构给出评级,买入评级18家,增持评级1家;过去90天内机构目标均价为393.97。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800001478.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430338725","title":"迈瑞医疗获得发明专利授权:“一种麻醉呼吸装置及方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2430338725","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430338725?lang=zh_cn&edition=full","pubTime":"2024-04-28 02:01","pubTimestamp":1714240898,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示迈瑞医疗新获得一项发明专利授权,专利名为“一种麻醉呼吸装置及方法”,专利申请号为CN201880099197.5,授权日为2024年4月26日。今年以来迈瑞医疗新获得专利授权198个,较去年同期增加了85.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800000329.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430746228","title":"迈瑞医疗(300760)3月31日股东户数6.14万户,较上期增加0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430746228","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430746228?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:27","pubTimestamp":1714123626,"startTime":"0","endTime":"0","summary":"证券之星消息,近日迈瑞医疗披露,截至2024年3月31日公司股东户数为6.14万户,较12月31日增加501.0户,增幅为0.82%。在医疗器械行业个股中,迈瑞医疗股东户数高于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.11万户。从股价来看,2023年12月31日至2024年3月31日,迈瑞医疗区间跌幅为3.15%,在此期间股东户数增加501.0户,增幅为0.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600041011.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430240056","title":"迈瑞医疗(300760.SZ)发布一季度业绩,净利润31.6亿元,同比增长22.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430240056","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430240056?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:17","pubTimestamp":1714123023,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈瑞医疗(300760.SZ)发布2024年第一季度报告,报告期内实现营业收入93.73亿元,同比增长12.06%,实现归属于上市公司股东的净利润31.6亿元,同比增长22.90%,实现归属于上市公司股东的扣除非经常性损益的净利润30.37亿元,同比增长20.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111650.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430324019","title":"迈瑞医疗(300760.SZ)发布2023年度业绩,净利润115.82亿元,同比增长20.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430324019","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430324019?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:12","pubTimestamp":1714122748,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈瑞医疗(300760.SZ)发布2023年年度报告,报告期内实现营业收入349.32亿元,同比增长15.04%,实现归属于上市公司股东的净利润115.82亿元,同比增长20.56%,实现归属于上市公司股东的扣除非经常性损益的净利润114.34亿元,同比增长20.04%。基本每股收益9.5586元。拟向全体股东每10股派发现金红利15元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111636.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430555469","title":"迈瑞医疗新注册《迈瑞BeneHeart C&S系列自动体外除颤器软件V2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2430555469","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430555469?lang=zh_cn&edition=full","pubTime":"2024-04-25 01:03","pubTimestamp":1713978189,"startTime":"0","endTime":"0","summary":"证券之星消息,近日迈瑞医疗(300760)新注册了《迈瑞BeneHeart C&S系列自动体外除颤器软件V2.0》项目的软件著作权。今年以来迈瑞医疗新注册软件著作权3个,较去年同期减少了72.73%。结合公司2023年中报财务数据,2023上半年公司在研发方面投入了18.51亿元,同比增37.13%。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500001032.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429795481","title":"4月24日迈瑞医疗现1笔折价14.49%的大宗交易 合计成交244.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429795481","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429795481?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:40","pubTimestamp":1713948047,"startTime":"0","endTime":"0","summary":"证券之星消息,4月24日迈瑞医疗发生大宗交易,交易数据如下:大宗交易成交价格244.44元,相对当日收盘价折价14.49%,成交1万股,成交金额244.44万元,买方营业部为财通证券股份有限公司杭州上塘路证券营业部,卖方营业部为国投证券股份有限公司广州新港东路证券营业部。近三个月该股共发生8笔大宗交易,合计成交1477.0手,折价成交6笔。截至2024年4月24日收盘,迈瑞医疗报收于285.85元,上涨0.47%,换手率0.22%,成交量2.65万手,成交额7.58亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400033396.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912418","title":"景顺长城新兴成长混合一季报出炉!刘彦春:偏好具有好的商业模式、在市场化竞争中取得优势的企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912418","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429912418?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:01","pubTimestamp":1713772860,"startTime":"0","endTime":"0","summary":"4月22日,景顺长城基金知名基金经理刘彦春管理的景顺长城新兴成长混合披露了一季报。我们仍然偏好那些具有好的商业模式、在市场化竞争中取得优势的企业,更关注那些可以处理好当期股东回报和未来发展的优秀公司。截至一季度末,刘彦春在管基金一共有6只,管理规模518.77亿元。其中,规模靠前的是272.5亿元的景顺长城新兴成长,这只产品也是刘彦春的代表作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-04-22/doc-inastanw9922292.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-04-22/doc-inastanw9922292.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429405962","title":"脑机接口又传重磅利好!全球最大神经拟态系统诞生,比人脑快200倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2429405962","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2429405962?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:24","pubTimestamp":1713752640,"startTime":"0","endTime":"0","summary":"英特尔打开AGI时代的一把“钥匙”?","market":"hk","thumbnail":"https://img3.gelonghui.com/9112e-0d1877a9-cc43-44da-abd0-0da5aff2eb86.png?guru_height=291&guru_width=480","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/9112e-0d1877a9-cc43-44da-abd0-0da5aff2eb86.png?guru_height=291&guru_width=480"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/722215","is_publish_highlight":false,"gpt_icon":0},{"id":"2429842319","title":"医药老三,没了1500亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2429842319","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2429842319?lang=zh_cn&edition=full","pubTime":"2024-04-21 17:23","pubTimestamp":1713691414,"startTime":"0","endTime":"0","summary":"成长性仍在","market":"hk","thumbnail":"https://img3.gelonghui.com/c9b00-962b4f89-aee5-4953-8e21-02be8673cf5d.jpg?guru_height=855&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/c9b00-962b4f89-aee5-4953-8e21-02be8673cf5d.jpg?guru_height=855&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/722008","is_publish_highlight":false,"gpt_icon":0},{"id":"2428359635","title":"迈瑞医疗4月19日现1笔大宗交易 成交金额261.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428359635","media":"智能小浪","top":-1,"share":"https://www.laohu8.com/m/news/2428359635?lang=zh_cn&edition=full","pubTime":"2024-04-19 17:00","pubTimestamp":1713517200,"startTime":"0","endTime":"0","summary":" 4月19日,迈瑞医疗收跌0.30%,收盘价为271.39元,发生1笔大宗交易,合计成交量1.2万股,成交金额261.31万元。 第1笔成交价格为217.76元,成交1.20万股,成交金额261.31万元,溢价率为-19.76%,买方营业部为中国中金财富证券有限公司上海分公司,卖方营业部为长城证券股份有限公司广东分公司。 进一步统计,近3个月内该股累计发生8笔大宗交易,合计成交金额为3754.33万元。该股近5个交易日累计上涨0.28%,主力资金合计净流入7667.51万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-04-19/doc-inaskezs9627235.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-04-19/doc-inaskezs9627235.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428553033","title":"《大行》瑞银最新中资股首选股名单(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2428553033","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428553033?lang=zh_cn&edition=full","pubTime":"2024-04-18 15:21","pubTimestamp":1713424860,"startTime":"0","endTime":"0","summary":"但该行对中国市场保持建设性看法,并继续以派息作为核心投资组合,将高股息股票作为投资组合的核心部分。该行更新了对中资股首选股名单,新纳入携程、紫金矿业、宇通客车、中国中车、农业银行、长江电力,同时剔出安踏、迈瑞医疗、中国中免及蒙牛。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180419153447753_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180419153447753_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1343318/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-10-16","address":"广东省深圳市南山区高新技术产业园区科技南十二路迈瑞大厦1-4层","stockEarnings":[{"period":"1week","weight":0.0706},{"period":"1month","weight":0.0822},{"period":"3month","weight":0.1351},{"period":"6month","weight":0.0911},{"period":"1year","weight":0.0057},{"period":"ytd","weight":0.0481}],"companyName":"深圳迈瑞生物医疗电子股份有限公司","boardCode":"AI0035","perCapita":"19731股","boardName":"专用设备制造业","registeredCapital":"121244万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 深圳迈瑞生物医疗电子股份有限公司主要从事医疗器械的研发、制造、营销及服务,主要产品涵盖三大领域:生命信息与支持、体外诊断以及医学影像。公司总部设在中国深圳,在北美、欧洲、亚洲、非洲、拉美等地区的超过30个国家设有40家境外子公司;在国内设有17家子公司,超过40家分支机构,形成了庞大的全球化研发、营销及服务网络。公司荣获“2022年度中国医疗设备优秀民族品牌金奖”、“2022峰值TOP 2022年度南山区经济突出贡献企业--工业增加值十强”、“2022年度南山区纳税百强企业(十强)”、“2022年度广东省质量信用A类医疗器械生产企业”、2022年度Wind ESG最佳实践上市公司-A股最佳实践奖、2022年度Wind ESG最佳实践上市公司-A股医疗保健行业最佳实践奖、2022中国医药上市公司ESG竞争力TOP20、第十六届中国上市公司ESG百强、2022年度中经大健康高质量发展企业、第五届中国卓越IR·2021-2022最佳ESG奖、第五届中国卓越IR·2021-2022最佳ESG奖、2022卓越社会责任企业、2023中国宠物医疗行业年度品牌盛典年度科技创新品牌奖和年度筑梦人才品牌奖、瑞派宠物医院突出贡献奖。","serverTime":1714647908369,"listedPrice":48.8,"stockholders":"61448人(较上一季度增加0.82%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈瑞医疗(300760)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈瑞医疗(300760)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈瑞医疗,300760,迈瑞医疗股票,迈瑞医疗股票老虎,迈瑞医疗股票老虎国际,迈瑞医疗行情,迈瑞医疗股票行情,迈瑞医疗股价,迈瑞医疗股市,迈瑞医疗股票价格,迈瑞医疗股票交易,迈瑞医疗股票购买,迈瑞医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈瑞医疗(300760)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈瑞医疗(300760)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}